203 related articles for article (PubMed ID: 31614726)
1. Enhanced Treatment Effects of Tilmicosin Against
Zhou K; Wang X; Chen D; Yuan Y; Wang S; Li C; Yan Y; Liu Q; Shao L; Huang L; Yuan Z; Xie S
Pharmaceutics; 2019 Oct; 11(10):. PubMed ID: 31614726
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the antibacterial activity of tilmicosin-SLN against
Zhu L; Cao X; Xu Q; Su J; Li X; Zhou W
Int J Nanomedicine; 2018; 13():4747-4755. PubMed ID: 30147316
[TBL] [Abstract][Full Text] [Related]
3. Enhanced antibacterial activity of tilmicosin against
Luo W; Liu J; Zhang S; Song W; Algharib SA; Chen W
J Vet Sci; 2022 Jan; 23(1):e1. PubMed ID: 34931502
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of antibacterial activity of tilmicosin against Staphylococcus aureus by solid lipid nanoparticles in vitro and in vivo.
Wang XF; Zhang SL; Zhu LY; Xie SY; Dong Z; Wang Y; Zhou WZ
Vet J; 2012 Jan; 191(1):115-20. PubMed ID: 21900026
[TBL] [Abstract][Full Text] [Related]
5. Preparation, characterization, and pharmacokinetics of tilmicosin- and florfenicol-loaded hydrogenated castor oil-solid lipid nanoparticles.
Ling Z; Yonghong L; Changqing S; Junfeng L; Li Z; Chunyu J; Xianqiang L
J Vet Pharmacol Ther; 2017 Jun; 40(3):293-303. PubMed ID: 27687707
[TBL] [Abstract][Full Text] [Related]
6. Solid Lipid Nanoparticles for Duodenum Targeted Oral Delivery of Tilmicosin.
Zhou K; Yan Y; Chen D; Huang L; Li C; Meng K; Wang S; Algharib SA; Yuan Z; Xie S
Pharmaceutics; 2020 Aug; 12(8):. PubMed ID: 32759764
[TBL] [Abstract][Full Text] [Related]
7. Antibacterial activity of enrofloxacin loaded gelatin-sodium alginate composite nanogels against intracellular
Luo W; Liu J; Algharib SA; Chen W
J Vet Sci; 2022 May; 23(3):e48. PubMed ID: 35618320
[TBL] [Abstract][Full Text] [Related]
8. Antibacterial activity of a novel glycyrrhizic acid-loaded chitosan composite nanogel in vitro against Staphylococcus aureus small colony variants.
Ju M; Liu J; Guan D; Leng N; Algharib SA; Dawood AS; Luo W
Curr Drug Deliv; 2023 Jan; ():. PubMed ID: 36650649
[TBL] [Abstract][Full Text] [Related]
9. Acute toxicity study of tilmicosin-loaded hydrogenated castor oil-solid lipid nanoparticles.
Xie S; Wang F; Wang Y; Zhu L; Dong Z; Wang X; Li X; Zhou W
Part Fibre Toxicol; 2011 Nov; 8():33. PubMed ID: 22098626
[TBL] [Abstract][Full Text] [Related]
10. Preparation and Characterization of Three Tilmicosin-loaded Lipid Nanoparticles: Physicochemical Properties and
Al-Qushawi A; Rassouli A; Atyabi F; Peighambari SM; Esfandyari-Manesh M; Shams GR; Yazdani A
Iran J Pharm Res; 2016; 15(4):663-676. PubMed ID: 28261309
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of
Liu X; Sun W; Wu N; Rong N; Kang C; Jian S; Chen C; Chen C; Zhang X
Vaccines (Basel); 2021 Mar; 9(3):. PubMed ID: 33807110
[No Abstract] [Full Text] [Related]
12. Tilmicosin- and florfenicol-loaded hydrogenated castor oil-solid lipid nanoparticles to pigs: Combined antibacterial activities and pharmacokinetics.
Ling Z; Yonghong L; Junfeng L; Li Z; Xianqiang L
J Vet Pharmacol Ther; 2018 Apr; 41(2):307-313. PubMed ID: 29139136
[TBL] [Abstract][Full Text] [Related]
13. Guar gum modified tilmicosin-loaded sodium alginate/gelatin composite nanogels for effective therapy of porcine proliferative enteritis caused by Lawsonia intracellularis.
Luo W; Meng K; Zhao Y; Liu J; Chen D; Xu C; Algharib SA; Dawood AS; Xie S
Int J Biol Macromol; 2023 Jul; 242(Pt 3):125084. PubMed ID: 37245769
[TBL] [Abstract][Full Text] [Related]
14. Comparison of tilmicosin and cephapirin as therapeutics for Staphylococcus aureus mastitis at dry-off.
Nickerson SC; Owens WE; Fox LK; Scheifinger CC; Shryock TR; Spike TE
J Dairy Sci; 1999 Apr; 82(4):696-703. PubMed ID: 10212455
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of parenterally or intramammarily administered tilmicosin or ceftiofur against Staphylococcus aureus mastitis during lactation.
Owens WE; Nickerson SC; Ray CH
J Dairy Sci; 1999 Mar; 82(3):645-7. PubMed ID: 10194686
[TBL] [Abstract][Full Text] [Related]
16. Impact of intramammary tilmicosin infusion as a dry cow therapy.
Mohammadsadegh M
J Vet Pharmacol Ther; 2018 Feb; 41(1):22-27. PubMed ID: 28600854
[TBL] [Abstract][Full Text] [Related]
17. Impact of Diclofenac Sodium on Tilmicosin-Induced Acute Cardiotoxicity in Rats (Tilmicosin and Diclofenac Cardiotoxicity).
Oda SS; Derbalah AE
Cardiovasc Toxicol; 2018 Feb; 18(1):63-75. PubMed ID: 28593443
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of antibacterial activity of nitric oxide-releasing polymeric particles against Staphylococcus aureus and Escherichia coli from bovine mastitis.
Cardozo VF; Lancheros CA; Narciso AM; Valereto EC; Kobayashi RK; Seabra AB; Nakazato G
Int J Pharm; 2014 Oct; 473(1-2):20-9. PubMed ID: 24979535
[TBL] [Abstract][Full Text] [Related]
19. A Comparative Study Between the Antibacterial Effect of Nisin and Nisin-Loaded Chitosan/Alginate Nanoparticles on the Growth of Staphylococcus aureus in Raw and Pasteurized Milk Samples.
Zohri M; Alavidjeh MS; Haririan I; Ardestani MS; Ebrahimi SE; Sani HT; Sadjadi SK
Probiotics Antimicrob Proteins; 2010 Dec; 2(4):258-66. PubMed ID: 26781321
[TBL] [Abstract][Full Text] [Related]
20. Ion pairing with linoleic acid simultaneously enhances encapsulation efficiency and antibacterial activity of vancomycin in solid lipid nanoparticles.
Kalhapure RS; Mocktar C; Sikwal DR; Sonawane SJ; Kathiravan MK; Skelton A; Govender T
Colloids Surf B Biointerfaces; 2014 May; 117():303-11. PubMed ID: 24667076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
